Evidence map›Paper›PMID 24204874›Full record

ArticlePloS one2013

Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infection.

Marise Pinheiro Nunes, Bárbara Fortes, João Luiz Silva-Filho, Eugênia Terra-Granado, Leonardo Santos, Luciana Conde, Isadora de Araújo Oliveira, Leonardo Freire-de-Lima, Marina Vieira Martins, Ana Acacia Sá Pinheiro and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Tumor-Suppressive Cross-Linking of Anti-International journal of molecular sciences · 2024
    Article
  3. Review
  4. Frontiers in cellular and infection microbiology · 2021
    Review
  5. The Glycan Structure ofMolecules (Basel, Switzerland) · 2020
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Role of Inactive and ActiveFrontiers in microbiology · 2017
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Immune Evasion Strategies of Trypanosoma cruzi.Journal of immunology research · 2015
    Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Marise Pinheiro NunesOswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Bárbara Fortes
João Luiz Silva-Filho
Eugênia Terra-Granado
Leonardo Santos
Luciana Conde
Isadora de Araújo Oliveira
Leonardo Freire-de-Lima
Marina Vieira Martins
Ana Acacia Sá Pinheiro
Christina Maeda Takyia
Célio Geraldo Freire-de-Lima
Adriane Regina Todeschini
George Alexandre Dosreis
Alexandre Morrot
Universidade Federal do Rio de Janeiro · BRFundação Oswaldo Cruz · BRInstituto Nacional do Câncer · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Trypanosoma cruzi infection is associated with severe T cell unresponsiveness to antigens and mitogens characterized by decreased IL-2 synthesis. Trypanosoma cruzi mucin (Tc Muc) has been implicated in this phenomenom. These molecules contain a unique type of glycosylation consisting of several sialylated O-glycans linked to the protein backbone via N-acetylglucosamine residues. METHODOLOGY/PRINCIPAL

findingsIn this study, we evaluated the ability of Tc Muc to modulate the activation of CD4(+) T cells. Our data show that cross-linking of CD3 on naïve CD4(+) T cells in the presence of Tc Muc resulted in the inhibition of both cytokine secretion and proliferation. We further show that the sialylated O-Linked Glycan residues from tc mucin potentiate the suppression of T cell response by inducing G1-phase cell cycle arrest associated with upregulation of mitogen inhibitor p27(kip1). These inhibitory effects cannot be reversed by the addition of exogenous IL-2, rendering CD4(+) T cells anergic when activated by TCR triggering. Additionally, in vivo administration of Tc Muc during T. cruzi infection enhanced parasitemia and aggravated heart damage. Analysis of recall responses during infection showed lower frequencies of IFN-γ producing CD4(+) T cells in the spleen of Tc Muc treated mice, compared to untreated controls. CONCLUSIONS/SIGNIFICANCE: Our results indicate that Tc Muc mediates inhibitory efects on CD4(+) T expansion and cytokine production, by blocking cell cycle progression in the G1 phase. We propose that the sialyl motif of Tc Muc is able to interact with sialic acid-binding Ig-like lectins (Siglecs) on CD4(+) T cells, which may allow the parasite to modulate the immune system.

Indexed as

AnimalsCD3 ComplexCD4-Positive T-LymphocytesCell Cycle CheckpointsCell ProliferationChagas DiseaseDisease SusceptibilityG1 PhaseInterferon-gammaInterleukin-2MaleMiceMice, Inbred BALB CMucinsSialoglycoproteinsTrypanosoma cruziCD3 ComplexInterferon-gammaInterleukin-2MucinsSialoglycoproteins

Identifiers

PMID24204874
PMCPMC3810146
OpenAlexW2070927523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.